Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

359

HTML

3873

Figures (1-4)

231

Tables (1-6)

230

Sum=4693

Aug 14, 2011 (publication date) through Nov 15, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 14, 2011; 17(30): 3503-3509
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3503

Table 3 Histological grade and signal intensity in the hepatobiliary phase in lesions which maintained portal blood flow

DN: Dysplastic nodule; Well: Well differentiated hepatocellular carcinoma (HCC); Mod: Moderately differentiated HCC; Poor: Poorly differentiated HCC.

^aSignificantly lower frequency, P < 0.05;

^bSignificantly higher frequency, P < 0.05.

Citation: Saito K, Moriyasu F, Sugimoto K, Nishio R, Saguchi T, Nagao T, Taira J, Akata S, Tokuuye K. Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule. World J Gastroenterol 2011; 17(30): 3503-3509
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3503.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3503